Author:
Ogiso Hideyuki,Adachi Seiji,Mabuchi Masatoshi,Horibe Yohei,Ohno Tomohiko,Suzuki Yusuke,Yamauchi Osamu,Kojima Takao,Takada Eri,Iwama Midori,Saito Koshiro,Iwashita Takuji,Ibuka Takashi,Yasuda Ichiro,Shimizu Masahito
Abstract
AbstractThe aim of this study was to clarify risk factors for esophageal candidiasis (EC) in immunocompetent patients in a community hospital. 7736 patients who underwent esophagogastroduodenoscopy at our hospital from April 2012 to July 2018 were enrolled. The relationships between EC and the following factors: age, gender, body mass index, lifestyle, lifestyle-related diseases, medication, and endoscopic findings were analyzed. EC was observed in 184 of 7736 cases (2.4% morbidity rate). Multivariate analysis revealed that significant risk factors for the development of EC were: diabetes mellitus {odds ratio (OR): 1.52}, proton pump inhibitor (PPI) use (OR: 1.69), atrophic gastritis (AG) (OR: 1.60), advanced gastric cancer (OR: 4.66), and gastrectomy (OR: 2.32). When severe EC (Kodsi grade ≥ II) was compared to mild EC (grade I), the most significant risk factors were advanced gastric cancer (OR: 17.6) and gastrectomy (OR: 23.4). When considering the risk of AG and PPI use with EC development, the risk increased as follows: AG (OR: 1.59), PPI use (OR: 2.25), and both (OR: 3.13). PPI use, AG, advanced gastric cancer and post-gastrectomy are critical risk factors for the development of EC. We suggest close monitoring for EC development when PPIs are administered to patients with these factors.
Publisher
Springer Science and Business Media LLC
Reference24 articles.
1. Robertson, K. D. & Mehta, D. Esophageal Candidiasis. in StatPearls (StatPearls Publishing, 2019).
2. Pappas, P. G. et al. Clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases society of America. Clin. Infect. Dis. 62, e1–e50 (2016).
3. Mohamed, A. A., Lu, X. & Mounmin, F. A. Diagnosis and treatment of esophageal candidiasis: Current updates. Can. J. Gastroenterol. Hepatol 2019, 3585136 (2019).
4. Vazquez, J. A. Optimal management of oropharyngeal and esophageal candidiasis in patients living with HIV infection. HIV AIDS (Auckl) 2, 89–101 (2010).
5. Takahashi, Y. et al. Long-term trends in esophageal candidiasis prevalence and associated risk factors with or without HIV infection: Lessons from an endoscopic study of 80,219 patients. PLoS ONE 10, e0133589 (2015).
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献